Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center explains the use of ipilimumab and nivolumab in advanced melanoma. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Use of Drug Combination, Ipilimumab and Nivolumab, in Advanced Melanoma
